Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Options Profit Calculator

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Covered Call Calculator

Cash-Secured Put Calculator

Long Call Calculator

Long Put Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Dr Reddy's Laboratories Ltd Stock News

RDYNYSE

Trade with Public

Trade with Public

$13.55

-0.08-0.59%

At close: May 21, 5:00 PM EST

$13.25

-0.30-2.21%

After Hours: 5:12 PM EST

OverviewNewsEarnings Options Dividends Analyst Ratings Short Interest Stock Report

Latest Dr Reddy's Laboratories Stock News | NYSE:RDY | Benzinga

Get the latest news on Dr Reddy's Laboratories stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Dr Reddy's Laboratories performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, May 18, 2026

PRO
Reported Saturday, Dr. Reddy's Breaks Ground ...
Benzinga Newsdesk

Saturday, May 16, 2026

Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push
Nabaparna Bhattacharya

Tuesday, May 12, 2026

PRO
Dr Reddy's Laboratories shares are trading lo...
Benzinga Newsdesk
PRO
Dr Reddy's Laboratories Q4 EPS $0.03 Misses $...
Benzinga Newsdesk
PRO
Dr Reddy's Received Marketing Authorization F...
Benzinga Newsdesk
Earnings Scheduled For May 12, 2026
Benzinga Insights

Wednesday, April 29, 2026

PRO
Dr. Reddy's Laboratories Receives Health Cana...
Benzinga Newsdesk

Tuesday, April 28, 2026

PRO
'Canada Approves Its First Generic Version of...
Benzinga Newsdesk

Thursday, April 23, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights

Wednesday, April 15, 2026

PRO
Dr. Reddy's Laboratories Russian Unit Fined R...
Benzinga Newsdesk

Tuesday, April 07, 2026

PRO
Dr. Reddy's Laboratories Enters Agreement For...
Benzinga Newsdesk

Monday, March 23, 2026

India's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply
Vandana Singh

Thursday, March 05, 2026

Dr. Reddy's Said Company Has Received The Establishment Inspection Report On March 04, 2026. The FDA Has Classified The Inspection Outcome As Voluntary Action Indicated And Concluded That The Inspection Is Officially Closed Under 21 CFR 20.64(D)(3)
Charles Gross

Friday, February 20, 2026

PRO
Dr. Reddy's Laboratories' Biologics License A...
Benzinga Newsdesk

Tuesday, February 17, 2026

PRO
'Dr Reddy's aims to launch generic obesity dr...
Benzinga Newsdesk

Monday, February 02, 2026

PRO
Shares of US-listed Indian companies are trad...
Benzinga Newsdesk

Friday, January 30, 2026

PRO
Coya Therapeutics Commences ~$11.1M Offering ...
Benzinga Newsdesk

Wednesday, January 21, 2026

PRO
Dr Reddy's Laboratories Q3 EPS $0.16, Inline,...
Benzinga Newsdesk
PRO
'Dr Reddy's to Start Selling Generic Ozempic ...
Benzinga Newsdesk

Wednesday, January 14, 2026

PRO
Dr. Reddy's Laboratories Rolls Out Over-The-C...
Benzinga Newsdesk
PRO
Dr. Reddy's Announced First-To-Market U.S. La...
Benzinga Newsdesk

Wednesday, December 31, 2025

PRO
Dr. Reddy's Switzerland Receives FDA Complete...
Benzinga Newsdesk

Monday, December 22, 2025

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights

Friday, December 12, 2025

FDA Weighs Rapid Review For Eli Lilly Obesity Pill As Novo Nordisk Nears Launch
Vandana Singh

Monday, December 08, 2025

PRO
Immutep And Dr. Reddy's Enter Collaboration A...
Benzinga Newsdesk

Tuesday, December 02, 2025

PRO
Dr. Reddy's Laboratories' Aurigene Oncology U...
Benzinga Newsdesk

Wednesday, October 29, 2025

PRO
Dr. Reddy's shares are trading lower after th...
Benzinga Newsdesk

Friday, October 24, 2025

PRO
Dr Reddy's Laboratories Q2 EPS $0.19 Beats $0...
Benzinga Newsdesk

Thursday, October 09, 2025

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs
Vandana Singh

Friday, October 03, 2025

PRO
Esperion, Dr. Reddy's Laboratories Reach Pate...
Benzinga Newsdesk

Monday, August 18, 2025

PRO
Extrovis And Dr. Reddy's Launch Authorized Ge...
Benzinga Newsdesk

Wednesday, July 23, 2025

PRO
'Dr Reddy's Joins Generic Drugmakers Readying...
Benzinga Newsdesk
PRO
Dr Reddy's Laboratories Q1 EPS $0.20 Beats $0...
Benzinga Newsdesk

Wednesday, June 11, 2025

PRO
Alvotech And Dr. Reddy's Partner To Co-Develo...
Benzinga Newsdesk

Thursday, June 05, 2025

Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug
Vandana Singh
PRO
Dr. Reddy's Laboratories shares are trading h...
Benzinga Newsdesk
PRO
HSBC Upgrades Dr Reddy's Laboratories to Buy,...
Benzinga Newsdesk
PRO
Alvotech And Dr. Reddy's Sign Agreement To Co...
Benzinga Newsdesk

Monday, May 12, 2025

PRO
Dr. Reddy's Laboratories shares are trading h...
Benzinga Newsdesk

Friday, May 09, 2025

PRO
Dr Reddy's Laboratories Q4 EPS $0.22 Beats $0...
Benzinga Newsdesk

Monday, April 14, 2025

PRO
Dr. Reddy's Denies Report Of 25% Workforce Co...
Benzinga Newsdesk

Wednesday, April 09, 2025

Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Vandana Singh

Thursday, March 27, 2025

PRO
Bio-Thera And Dr. Reddy's Reach Exclusive Com...
Benzinga Newsdesk

Tuesday, March 18, 2025

PRO
Alvotech And Dr. Reddy's Announce FDA Accepta...
Benzinga Newsdesk

Thursday, February 06, 2025

PRO
Dr. Reddy's Laboratories Subsidiary Announced...
Benzinga Newsdesk
PRO
Shanghai Henlius Biotech Enters License Agree...
Benzinga Newsdesk

Thursday, January 23, 2025

Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business
Vandana Singh
PRO
Dr. Reddy's Laboratories shares are trading l...
Benzinga Newsdesk
PRO
Dr Reddy's Laboratories Q3 2025 GAAP EPS $0.2...
Benzinga Newsdesk
Earnings Scheduled For January 23, 2025
Benzinga Insights

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved